|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.610 USD | -4.73% |
|
+1.90% | -19.10% |
| Market Cap | 428M 375M 346M 319M 606M 40.87B 616M 4.13B 1.62B 20.13B 1.61B 1.57B 69.21B | P/E 2026 * |
-1.82x | P/E 2027 * | -2.57x |
|---|---|---|---|---|---|
| Enterprise Value | 389M 340M 314M 290M 550M 37.1B 559M 3.75B 1.47B 18.27B 1.46B 1.43B 62.83B | EV / Sales 2026 * |
3.03x | EV / Sales 2027 * | 2.5x |
| Free-Float |
3.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Autolus Therapeutics plc
| 1 day | -4.73% | ||
| 1 week | +1.90% | ||
| Current month | +0.62% | ||
| 1 month | +3.21% | ||
| 3 months | +8.05% | ||
| 6 months | -11.05% | ||
| Current year | -19.10% |
| 1 week | 1.54 |  | 1.74 |
| 1 month | 1.46 | | 1.74 |
| Current year | 1.18 | | 2.07 |
| 1 year | 1.18 | | 2.7 |
| 3 years | 1.1 | | 7.45 |
| 5 years | 1.1 | | 7.9 |
| 10 years | 1.1 | | 53.24 |
| Manager | Title | Age | Since |
|---|---|---|---|
Martin Pulé
CTO | Chief Tech/Sci/R&D Officer | 53 | 31/08/2014 |
Christian Itin
CEO | Chief Executive Officer | 61 | 29/02/2016 |
Robert Dolski
DFI | Director of Finance/CFO | 56 | 06/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Christian Itin
CHM | Chairman | 61 | 30/09/2014 |
John Berriman
BRD | Director/Board Member | 78 | 31/07/2014 |
Cynthia Butitta
BRD | Director/Board Member | 71 | 28/02/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-28 | Free | Director | 79,167 | 0.0477% | ||
| 06-28 | Free | Director | 79,167 | 0.0477% | ||
| 06-28 | Free | Director | 79,167 | 0.0477% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.73% | +1.90% | -34.82% | -34.29% | 428M | |
| -0.51% | +1.57% | +17.05% | -7.30% | 67.61B | |
| -5.16% | -8.63% | +38.70% | +203.59% | 51.6B | |
| +5.28% | +39.50% | +39.50% | +39.50% | 43B | |
| -2.10% | +0.89% | -48.99% | -53.63% | 40.94B | |
| +0.12% | -7.85% | +48.39% | -28.83% | 29.4B | |
| -10.83% | -14.41% | +102.94% | -44.10% | 27.09B | |
| -1.53% | -0.13% | +70.16% | +85.73% | 23.32B | |
| +3.88% | +2.16% | +11.36% | +192.66% | 19.92B | |
| -1.59% | -1.63% | +64.87% | +130.98% | 16.91B | |
| Average | -1.72% | -2.53% | +30.91% | +48.43% | 32.02B | |
| Weighted average by Cap. | -1.36% | -2.83% | +31.22% | +48.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 129M 112M 104M 95.81M 182M 12.26B 185M 1.24B 487M 6.04B 483M 472M 20.77B | 191M 167M 154M 142M 270M 18.21B 275M 1.84B 723M 8.97B 717M 701M 30.85B |
| Net income | -242M -211M -195M -180M -342M -23.04B -347M -2.33B -914M -11.35B -907M -887M -39.01B | -184M -161M -148M -137M -260M -17.53B -264M -1.77B -696M -8.63B -690M -675M -29.68B |
| Net Debt | -39.53M -34.58M -31.89M -29.46M -55.89M -3.77B -56.83M -381M -150M -1.86B -148M -145M -6.39B | 48.41M 42.35M 39.06M 36.08M 68.45M 4.62B 69.6M 467M 183M 2.27B 182M 178M 7.82B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | US$1.610 | -4.73% | 1,348,300 |
| 09/07/26 | US$1.690 | -0.59% | 1,111,045 |
| 08/07/26 | US$1.700 | +5.59% | 1,673,442 |
| 07/07/26 | US$1.610 | -1.23% | 755,323 |
| 06/07/26 | US$1.630 | +3.16% | 1,039,035 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AUTL Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
